Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

AGM Statement

17 Jun 2021 07:00

RNS Number : 1544C
Anpario PLC
17 June 2021
 

17 June 2021

 

Anpario plc("Anpario" or the "Company")

 

AGM Statement

 

Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today. Peter Lawrence, Chairman, will make the following comments:

 

"The Board would firstly like to thank all our staff and other stakeholders for their continued efforts in ensuring production and delivery of our products to our customers and subsidiaries around the world especially during this challenging period caused by the Covid 19 pandemic.

 

The Company has delivered good sales and improved profit performance with sales at a similar level to last year, which was a very strong comparative period as customers had increased stock levels at the onset of the pandemic. Most regions are performing to plan with China experiencing a very strong performance, benefiting from last year's ban on anti-biotic growth promoters (AGPs) in animal feed. South East Asia's performance is, however, weaker as countries imposed new lockdowns in response to increasing infection rates and, with less tourism which has reduced overall protein consumption.

 

Our Brexit contingency plans are working well, helping to reduce disruption and we now look forward to our efforts coming to fruition now supported by our European stockholding hub.

 

As with most industries, we are experiencing raw material price inflation and some disruption in our supply chains and global shipping operations. However, we are implementing price increases to help mitigate the increase in costs and our export and logistics team is managing to overcome the logistics issues. We expect these challenges to continue until the last quarter of this year.

 

It is worth noting that Anpario's unique formulation technology also benefits customers as we are able to offer solutions which are more cost effective than alternative competitor products.

 

We are encouraged by some recent business development successes including a large Brazilian poultry integrator using Orego-Stim® and growth in Latin America for our aquaculture products, which are currently being launched in specific countries across Asia. Our exciting growth opportunities and strong balance sheet, which is reflected in our strong cash position, gives me confidence that the Company will continue to develop and grow in the years ahead.

 

Finally, this is my last AGM as I retire from the Board today. I would therefore like to take the opportunity to thank all staff and shareholders for their loyalty and support of Anpario in helping to build a successful company which has delivered significant shareholder value. As I hand over the Chair to Kate Allum, I am confident that the board with its newer members, will successfully continue to steer the company through these unusual times to ensure to deliver value to our shareholders.

 

The Company's interims for the six months period ended 30 June 2021 are expected to be announced on 15 September 2021."

 

 

Enquiries:

Anpario plc

Richard Edwards, Chief Executive Officer

+44 (0)7776 417 129

Karen Prior, Group Finance Director

+44 (0)1909 537 380

Peel Hunt LLP (NOMAD and broker)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFSERTIRLIL
Date   Source Headline
23rd Oct 20087:00 amRNSAnglo Platinum Quarterly Review and Prod Report
23rd Sep 200812:00 pmRNSDirectorate Change
20th Aug 20089:42 amRNSDividend Declaration
1st Aug 20084:30 pmRNSDirector/PDMR Shareholding
28th Jul 20088:00 amRNSInterim Results
28th Jul 20088:00 amRNSAnglo Platinum Limited
23rd Jul 200812:32 pmRNSBlocklisting Interim Review
18th Jul 20082:32 pmRNSBlocklisting Interim Review
17th Jul 200812:15 pmRNSBlocklisting Interim Review
15th Jul 200811:19 amRNSBlocklisting Interim Review
14th Jul 200811:36 amRNSTrading Statement
2nd Jul 20083:07 pmRNSDirectorate Change
13th May 20089:34 amRNSDirectorate Change
13th May 20089:30 amRNSAnglo Platinum CEO
30th Apr 20082:31 pmRNSDividend Declaration
29th Apr 200811:25 amRNSNew order mining rights
29th Apr 200811:03 amRNSMining Rights Conversions
29th Apr 20087:00 amRNSFirst Quarter Review
2nd Apr 20087:00 amRNSFinal Results
11th Mar 20089:43 amRNSDividend conversion rate
10th Mar 20081:04 pmRNSRevised Conversion Price
7th Mar 20081:54 pmRNSDirector/PDMR Shareholding
7th Mar 20089:35 amRNSEmployee Share Scheme
15th Feb 20089:18 amRNSSmelter Shutdown
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSAnglo Platinum
31st Jan 20089:50 amRNSPlatinum Transaction
31st Jan 20089:27 amRNSJoint Transaction
25th Jan 20085:38 pmRNSEnergy Supply Talks
23rd Jan 20082:24 pmRNSInterruption: Mine Production
23rd Jan 200811:07 amRNSDirectorate Change
17th Jan 20089:57 amRNSBlocklisting Interim Review
11th Jan 200812:16 pmRNSBlock listing application
16th Nov 20072:00 pmRNSAnglo Platinum Announcement
16th Nov 20071:56 pmRNSReduction in target
7th Nov 200710:12 amRNSProposed Transactions
2nd Nov 20072:00 pmRNSDirectorate Change
26th Oct 20073:02 pmRNSDividend Declaration
11th Oct 20071:00 pmRNSDirectorate Change
1st Oct 20073:03 pmRNSDirector/PDMR Shareholding
25th Sep 20077:01 amRNSInterim Results
4th Sep 20077:01 amRNSNotification
24th Aug 20073:23 pmRNSWage negotiations
22nd Aug 20079:09 amRNSDividend Conversion Rate
6th Aug 20074:13 pmRNSDirector/PDMR Shareholding
1st Aug 20077:02 amRNSChange of Adviser
30th Jul 200712:43 pmRNSDirectorate Change
30th Jul 20078:00 amRNSInterim Results
30th Jul 20078:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.